Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy
In recent years, the role of biocompatible nanocarriers (BNs) and their cancer cell targeting efficiency in photodynamic therapy (PDT) holds potential benefits for cancer treatment. Biocompatible and biodegradable nanoparticles are successfully used as carrier molecules to deliver cancer drugs and p...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Chemistry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.969809/full |
| _version_ | 1798042380774932480 |
|---|---|
| author | Sathish Sundar Dhilip Kumar Heidi Abrahamse |
| author_facet | Sathish Sundar Dhilip Kumar Heidi Abrahamse |
| author_sort | Sathish Sundar Dhilip Kumar |
| collection | DOAJ |
| description | In recent years, the role of biocompatible nanocarriers (BNs) and their cancer cell targeting efficiency in photodynamic therapy (PDT) holds potential benefits for cancer treatment. Biocompatible and biodegradable nanoparticles are successfully used as carrier molecules to deliver cancer drugs and photosensitizers due to their material safety in the drug delivery system. Biocompatible nanocarriers are non-toxic and ensure high-level biocompatibility with blood, cells, and physiological conditions. The physicochemical properties of BNs often enable them to modify their surface chemistry, which makes conjugating specific ligands or antibodies to achieve cancer cell targeting drug delivery in PDT. This review article focuses on the various types of BNs used in targeted drug delivery, physicochemical properties, and surface chemistry of BNs in targeted drug delivery, advantages of BNs in drug delivery systems, and the targeting efficiency of BNs on some specific targeting receptors for cancer therapy. Furthermore, the review briefly recaps the nanocarrier-based targeted approaches in cancer PDT. |
| first_indexed | 2024-04-11T22:34:42Z |
| format | Article |
| id | doaj.art-55d41631b6df4cb8a8720159a2cf6f96 |
| institution | Directory Open Access Journal |
| issn | 2296-2646 |
| language | English |
| last_indexed | 2024-04-11T22:34:42Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Chemistry |
| spelling | doaj.art-55d41631b6df4cb8a8720159a2cf6f962022-12-22T03:59:15ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462022-08-011010.3389/fchem.2022.969809969809Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapySathish Sundar Dhilip KumarHeidi AbrahamseIn recent years, the role of biocompatible nanocarriers (BNs) and their cancer cell targeting efficiency in photodynamic therapy (PDT) holds potential benefits for cancer treatment. Biocompatible and biodegradable nanoparticles are successfully used as carrier molecules to deliver cancer drugs and photosensitizers due to their material safety in the drug delivery system. Biocompatible nanocarriers are non-toxic and ensure high-level biocompatibility with blood, cells, and physiological conditions. The physicochemical properties of BNs often enable them to modify their surface chemistry, which makes conjugating specific ligands or antibodies to achieve cancer cell targeting drug delivery in PDT. This review article focuses on the various types of BNs used in targeted drug delivery, physicochemical properties, and surface chemistry of BNs in targeted drug delivery, advantages of BNs in drug delivery systems, and the targeting efficiency of BNs on some specific targeting receptors for cancer therapy. Furthermore, the review briefly recaps the nanocarrier-based targeted approaches in cancer PDT.https://www.frontiersin.org/articles/10.3389/fchem.2022.969809/fullnanocarriersphotodynamic therapyphotosensitizerstargeted drug deliverycancersurface modification |
| spellingShingle | Sathish Sundar Dhilip Kumar Heidi Abrahamse Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy Frontiers in Chemistry nanocarriers photodynamic therapy photosensitizers targeted drug delivery cancer surface modification |
| title | Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy |
| title_full | Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy |
| title_fullStr | Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy |
| title_full_unstemmed | Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy |
| title_short | Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy |
| title_sort | recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy |
| topic | nanocarriers photodynamic therapy photosensitizers targeted drug delivery cancer surface modification |
| url | https://www.frontiersin.org/articles/10.3389/fchem.2022.969809/full |
| work_keys_str_mv | AT sathishsundardhilipkumar recentadvancesinthedevelopmentofbiocompatiblenanocarriersandtheircancercelltargetingefficiencyinphotodynamictherapy AT heidiabrahamse recentadvancesinthedevelopmentofbiocompatiblenanocarriersandtheircancercelltargetingefficiencyinphotodynamictherapy |